How do you manage a patient with a high risk of suicide and self-harm who requests a prescription for lorazepam (Ativan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

I would not prescribe lorazepam to a patient at high risk for suicide and self-harm. Instead, I would conduct a thorough suicide risk assessment, including asking about specific plans, means, and intent, as recommended by the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guidelines 1. If the patient is at imminent risk, I would arrange immediate psychiatric hospitalization, either voluntarily or involuntarily if necessary. For outpatient management of a patient with less imminent risk, I would develop a comprehensive safety plan including removal of lethal means, identification of warning signs, coping strategies, emergency contacts, and crisis resources.

Some key points to consider in managing a patient with a high risk of suicide and self-harm include:

  • Conducting a thorough suicide risk assessment
  • Developing a comprehensive safety plan
  • Considering prescription of an SSRI antidepressant, such as sertraline 50mg daily or fluoxetine 20mg daily, for underlying depression, with close follow-up within 1-2 weeks
  • Referring the patient to psychotherapy, particularly cognitive behavioral therapy (CBT) or dialectical behavior therapy (DBT), as these therapies have been shown to reduce suicidal ideation and behavior 1
  • Ensuring the patient has 24-hour crisis resources, including the suicide prevention hotline

Benzodiazepines like lorazepam are generally avoided in suicidal patients as they can disinhibit behavior, worsen depression, and have high lethality in overdose, as well as carry addiction potential 1. If anxiety symptoms are severe, I might consider a small quantity (3-5 tablets) of a less lethal medication like hydroxyzine 25-50mg as needed, with frequent reassessment.

It's also important to note that evidence supports the use of a crisis response plan for persons with suicidal ideation, which involves a collaborative approach between patient and clinician, including a semi-structured interview, identification of clear signs of crisis, and collaborative identification of social support and crisis resources 1.

From the FDA Drug Label

The use of benzodiazepines, including lorazepam, exposes users to the risks of abuse, misuse, and addiction, which can lead to overdose or death Before prescribing lorazepam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction (e.g., using a standardized screening tool). Use of lorazepam, particularly in patients at elevated risk, necessitates counseling about the risks and proper use of lorazepam along with monitoring for signs and symptoms of abuse, misuse, and addiction Lorazepam is not recommended for use in patients with a primary depressive disorder or psychosis.

Management of a patient with a high risk of suicide and self-harm who requests a prescription for lorazepam (Ativan) should involve:

  • Assessing the patient's risk for abuse, misuse, and addiction using a standardized screening tool 2
  • Counseling the patient about the risks and proper use of lorazepam
  • Monitoring for signs and symptoms of abuse, misuse, and addiction
  • Considering alternative treatment options, as lorazepam is not recommended for use in patients with a primary depressive disorder or psychosis 2
  • A gradual taper to discontinue lorazepam or reduce the dosage to reduce the risk of withdrawal reactions 2

From the Research

Managing Patients with High Risk of Suicide and Self-Harm

When managing a patient with a high risk of suicide and self-harm who requests a prescription for lorazepam (Ativan), several factors should be considered:

  • The patient's mental health history and current diagnosis
  • The potential risks and benefits of prescribing lorazepam
  • Alternative treatment options

Risks Associated with Antidepressants and Benzodiazepines

Studies have shown that certain antidepressants, such as mirtazapine, venlafaxine, and trazodone, are associated with a higher risk of suicide and self-harm 3. Additionally, benzodiazepines like lorazepam can increase the risk of suicidal behavior, particularly in the first 28 days of treatment 3, 4, 5.

  • The risk of suicidal behavior is increased in the first month after starting antidepressants, especially during the first 1 to 9 days 4
  • The risk of self-harm is also increased during this period, with rates remaining high in the first 28 days after stopping treatment 3

Considerations for Prescribing Lorazepam

Given the potential risks associated with lorazepam, it is essential to carefully evaluate the patient's needs and consider alternative treatment options:

  • Lorazepam may be prescribed for short-term use in patients with severe anxiety or insomnia, but its use should be closely monitored 6
  • Alternative treatments, such as cognitive-behavioral therapy or other medications, may be more effective and safer for patients with a high risk of suicide and self-harm 3, 4, 5, 7

Monitoring and Follow-up

Patients prescribed lorazepam or other medications that may increase the risk of suicidal behavior should be closely monitored:

  • Regular follow-up appointments should be scheduled to assess the patient's mental health and adjust treatment as needed 3, 4, 5, 7
  • Patients should be warned about the potential risks of suicidal behavior and instructed to seek immediate medical attention if they experience any symptoms of self-harm or suicidal ideation 7

Related Questions

What is the mechanism by which depression worsened and suicidal thoughts developed in a patient taking Zepbound (Escitalopram)?
What is the best psychotropic approach for a 61-year-old female nursing‑home resident with schizophrenia who had breakthrough psychosis on maximum dose of ziprasidone (Geodon), was switched to risperidone (Risperdal) 1 mg in the morning and 2 mg in the evening for one month, and now presents with garbled speech, slowed thought processing, and staring spells?
What is the appropriate initial dose and dosing frequency of antipsychotic medication for a 66‑year‑old patient with unspecified dementia who is experiencing false beliefs (psychotic symptoms)?
What is the appropriate management for a 70‑year‑old patient with frontal‑lobe dementia who is aggressive toward other nursing‑home residents and is currently on buspirone 20 mg three times daily, olanzapine (Zyprexa) 5 mg at bedtime, olanzapine orally disintegrating tablet (Zyprexa Zydis) 2.5 mg at noon, sertraline (Zoloft) 100 mg daily, levetiracetam (Keppra) 500 mg twice daily, divalproex sodium (Depakote) 500 mg at bedtime, and mirtazapine (Remeron) 3.75 mg nightly, with no psychiatrist available and awaiting admission to a psychiatric hospital?
In a 52-year-old patient with schizophrenia and chronic pain who is taking amitriptyline 50 mg nightly, quetiapine (Seroquel) 150 mg nightly, ziprasidone (Geodon) 160 mg nightly, and gabapentin 800 mg three times daily, and who is experiencing irritability, anger, mood lability, and severe insomnia, what medication adjustments and regimen would you recommend?
What could cause significant abdominal bloating after consuming pizza?
What are the indications for topical methylene blue (methylthioninium chloride) use on the skin?
What are the criteria for lung transplant in patients with idiopathic pulmonary fibrosis (IPF)?
How do you manage a patient at high risk of suicide and self-harm who requests a prescription for lorazepam (Ativan), then presents to the emergency department (ED), informs a psychiatrist nurse that you discontinued their lorazepam, and subsequently notifies a medical body about your decision?
What is the relationship between croup and dextromethorphan (Dextromethorphan)?
What are the gynecological complications of Hypermobile Ehlers-Danlos Syndrome (hEDS) and considerations for a full hysterectomy in a 39-year-old patient with hEDS?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.